Friday, January 27, 2023

FDA Advisers Vote to Replace Original COVID Vaccine With Bivalent Boosters Despite Lack of Clinical Trial Data



Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free. Advisers to the U.S.

ORIGINAL LINK